Skip to content
Dose Brief
Menu
No. 370 here · Grade C

Aurelius Health Group review

Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+.

Visit Aurelius Health Group Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
Not disclosed
Tirzepatide
From $199/mo (microdose tier, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Prices read from Aurelius Health Group's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://www.aureliushealthgroup.com/ on 2026-08-01 and this row reflects what that page says. The line we publish is From $199/mo (microdose tier, compounded). There is no earlier reading of ours to compare it against yet.

The scorecard

Aurelius Health Group scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability64/100
Transparency72/100
Access Breadth40/100
Clinical Oversight76/100
Track Record54/100

What we like

  • Pricing fully published and bundled: $89 first month, then $199/mo all-in — more transparent than most compounded brands
  • LegitScript Certified
  • Care-inclusive model: consults, monthly monitoring, and secure messaging rather than Rx-only
  • Unusually candid about the limited evidence base for microdosing

The caveats

  • The advertised $89 is a first-month new-patient rate; every month after it is $199
  • This is a 1 mg microdose program and nothing else — no labeled therapeutic dose is sold, so it is not an alternative to a full-dose prescription
  • No state count is published, only 'most US states', confirmed at intake
  • The site's own comparison table calls 2.4 mg/week the tirzepatide 'standard full dose'; 2.4 mg is the semaglutide maintenance dose, and tirzepatide is labeled 2.5-15 mg/week
  • Compounded tirzepatide is not an FDA-approved finished product

The brief

Best for: Readers who want transparent, care-inclusive compounded tirzepatide microdosing. Aurelius Health Group is a telehealth platform built around compounded tirzepatide microdosing — a low-dose dual GIP/GLP-1 protocol rather than standard full-dose therapy — with optional NAD+.

Ranked #370 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit Aurelius Health Group

Before you decide

The questions readers ask next after reading about Aurelius Health Group.

Closest here

The providers scoring nearest Aurelius Health Group — the realistic shortlist if you're weighing it.

Weighing Aurelius Health Group against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Aurelius Health Group, and every provider that outranks it is listed on the Aurelius Health Group alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Aurelius Health Group's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Aurelius Health Group's site. Not medical advice; see our disclosure.

← Back to all rankings